Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-24-005510

Director bought 96,155 shares at $1.04 ($100,001)

From the SEC's structured data for this filing

Trades in this filing

BAILEY DON M · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-02-08 Purchase : show line 1 in the form +96,155 $1.04 $100,001 158,801 I
Open-market purchases · 96,155 sh · avg $1.04 · $100,001
Loading xslF345X05/ownership.xml…